Navigation Links
PacificGMP to Merge With Pacific Biopharma Group and Create Innovative US-Compliant cGMP Contract Biomanufacturing Facility in China
Date:6/18/2008

SAN DIEGO, June 18 /PRNewswire/ -- PacificGMP and Pacific Biopharma Group (PBG) announced that they have signed a definitive merger agreement and will develop a cGMP (current good manufacturing practices) biologics contract manufacturing organization (CMO) in Taizhou, China. At approximately 200,000 square feet, the Taizhou-based CMO, called China Quantitative Biomedicine (CQB), will be one of the largest single-use biomanufacturing facilities in the US or China. Construction of the facility in Taizhou is expected to be completed in August 2008 with internal construction and equipment installation expected to be completed by the end of 2008.

Under conditions of the merger agreement, PacificGMP will receive funds to expand its operation in San Diego and assist in the development of the Taizhou facility and preparations for FDA and EMEA audits. The new facility is a showcase laboratory and part of a new biopharmaceutical park called China Medical City (CMC). CMC is a 12 km2 life sciences focused science park located 2.5 hrs outside of Shanghai in Jiangsu Province, the leading pharmaceutical manufacturing province in China. The facility will be modeled after PacificGMP's San Diego facility that utilizes single-use technology throughout the biomanufacturing process. Single-use technology has far fewer system requirements than traditional re-usable biomanufacturing systems and significantly reduces the cost of product manufacturing.

"We believe a significant opportunity exists for global leadership in single-use contract manufacturing services," said Gary Pierce, Chief Business Officer of PacificGMP and new Chief Operating Officer of PBG. "PacificGMP brings know how and experience in single-use contract manufacturing and PBG brings management and operational know how and experiences in both the US and China as well as significant investment expansion capital."

"We look forward to contributing to the development of a state-of-the-art biomanufacturing facility in China to address the growing demand for contract manufacturing services and the rise of the Asian market for protein therapeutics," added Mr. Pierce. "This marks an important development in our organization that will benefit our customers by allowing us to expand the breadth of cost-effective quality services in San Diego and give our customers the option of eventual overseas manufacturing."

About PacificGMP

PacificGMP is a Contract Manufacturing Organization (CMO) and leader in the industry in single-use technology for development and manufacturing of biologics. Single-use technology eliminates the risk of cross-contamination, has fewer system requirements and significantly reduces the time required to initiate production. Benefits to clients include rapid project turnaround and the most cost effective solution in the industry. PacificGMP partners with drug developers by providing a range of cGMP and non-GMP services from early stages of process design, development and scale-up, to preclinical and clinical manufacturing. More information can be found by visiting the Company's web site at http://www.pacificGMP.com.

About Pacific Biopharma Group

Pacific Biopharma is a Cayman based company focused on global solutions to cost-effective, US-compliant drug development contract services.

Contact:

Andrea Lynn

619-993-7629

alynn@pacificgmp.com


'/>"/>
SOURCE PacificGMP
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. PacificGMP Announces Agreement with BD Biosciences for Cell Banking and cGMP Antibody Manufacturing
2. Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
3. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
4. VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
5. Proxy Governance and Egan-Jones Recommend Renovis Shareholders Vote For Merger With Evotec
6. Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec
7. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
8. Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement
9. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
10. VaxGen and Raven Terminate Merger Agreement
11. Publication Addresses Misconceptions About Emergency Contraception
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... Market with the addition of its newest module, US Hemostats & Sealants. , ... thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
Breaking Biology Technology:
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):